Vectus Biosystems Ltd

ASX:VBS ISIN:AU000000VBS9

Vectus BioSystems Ltd ASX:VBSVectus Biosystems Ltd (ASX:VBS) was founded on the groundbreaking discoveries by Dr Karen Duggan and her team. Their insight into the function of the native Vasoactive Intestinal Peptide (VIP), combined with years of research and successful testing to date, has led to the development of a new class of mimetic drug candidates and a drug library supported by a portfolio of intellectual property.

  

News

VIDEO PPR-TV: Vectus Biosystems Ltd (ASX:VBS) Raises $5.1 Million, Lists on Australian Stock Exchange

🕔2/26/2016 9:29:38 AM 32470

Vectus Biosystems Ltd (ASX:VBS) has listed on the ASX after raising A$5.1 million through an IPO to continue its search for an effective treatment for fibrosis and high blood pressure.

Read Full Article
###

5,123 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 27) (Since Published: 5123) 

Company Data

    Headquarters
  • Level 3, 11 Julius Avenue,
    North Ryde NSW 2113
    Australia
  • Telephone
  • +61 2 8876 8200 
  • Fax
  • +61 2 9870 7420  
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.vectusbiosystems.com.au

Social Media